296 related articles for article (PubMed ID: 11790798)
21. Phosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis.
Gerboth S; Frittoli E; Palamidessi A; Baltanas FC; Salek M; Rappsilber J; Giuliani C; Troglio F; Rolland Y; Pruneri G; Kreutmair S; Pallavicini I; Zobel M; Cinquanta M; Minucci S; Gomez C; Santos E; Illert AL; Scita G
Leukemia; 2018 Mar; 32(3):820-827. PubMed ID: 28819285
[TBL] [Abstract][Full Text] [Related]
22. Differential motility of p190bcr-abl- and p210bcr-abl-expressing cells: respective roles of Vav and Bcr-Abl GEFs.
Daubon T; Chasseriau J; El Ali A; Rivet J; Kitzis A; Constantin B; Bourmeyster N
Oncogene; 2008 Apr; 27(19):2673-85. PubMed ID: 18059343
[TBL] [Abstract][Full Text] [Related]
23. The protein tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-Vav.
Katzav S; Sutherland M; Packham G; Yi T; Weiss A
J Biol Chem; 1994 Dec; 269(51):32579-85. PubMed ID: 7798261
[TBL] [Abstract][Full Text] [Related]
24. Control of intramolecular interactions between the pleckstrin homology and Dbl homology domains of Vav and Sos1 regulates Rac binding.
Das B; Shu X; Day GJ; Han J; Krishna UM; Falck JR; Broek D
J Biol Chem; 2000 May; 275(20):15074-81. PubMed ID: 10748082
[TBL] [Abstract][Full Text] [Related]
25. PI 3-kinase activation in BCR/abl-transformed hematopoietic cells does not require interaction of p85 SH2 domains with p210 BCR/abl.
Jain SK; Susa M; Keeler ML; Carlesso N; Druker B; Varticovski L
Blood; 1996 Sep; 88(5):1542-50. PubMed ID: 8781408
[TBL] [Abstract][Full Text] [Related]
26. An SH2 domain-dependent, phosphotyrosine-independent interaction between Vav1 and the Mer receptor tyrosine kinase: a mechanism for localizing guanine nucleotide-exchange factor action.
Mahajan NP; Earp HS
J Biol Chem; 2003 Oct; 278(43):42596-603. PubMed ID: 12920122
[TBL] [Abstract][Full Text] [Related]
27. The tyrosine phosphatase PTP1C associates with Vav, Grb2, and mSos1 in hematopoietic cells.
Kon-Kozlowski M; Pani G; Pawson T; Siminovitch KA
J Biol Chem; 1996 Feb; 271(7):3856-62. PubMed ID: 8632004
[TBL] [Abstract][Full Text] [Related]
28. Proto-oncogene products Vav and c-Cbl are involved in the signal transduction through Grb2/Ash in hematopoietic cells.
Hanazono Y; Odai H; Sasaki K; Iwamatsu A; Yazaki Y; Hirai H
Acta Haematol; 1996; 95(3-4):236-42. PubMed ID: 8677749
[TBL] [Abstract][Full Text] [Related]
29. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.
Skorski T; Bellacosa A; Nieborowska-Skorska M; Majewski M; Martinez R; Choi JK; Trotta R; Wlodarski P; Perrotti D; Chan TO; Wasik MA; Tsichlis PN; Calabretta B
EMBO J; 1997 Oct; 16(20):6151-61. PubMed ID: 9321394
[TBL] [Abstract][Full Text] [Related]
30. The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells.
Klejman A; Schreiner SJ; Nieborowska-Skorska M; Slupianek A; Wilson M; Smithgall TE; Skorski T
EMBO J; 2002 Nov; 21(21):5766-74. PubMed ID: 12411494
[TBL] [Abstract][Full Text] [Related]
31. The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner.
Ribon V; Hubbell S; Herrera R; Saltiel AR
Mol Cell Biol; 1996 Jan; 16(1):45-52. PubMed ID: 8524328
[TBL] [Abstract][Full Text] [Related]
32. Deletion of the Src homology 3 domain and C-terminal proline-rich sequences in Bcr-Abl prevents Abl interactor 2 degradation and spontaneous cell migration and impairs leukemogenesis.
Dai Z; Kerzic P; Schroeder WG; McNiece IK
J Biol Chem; 2001 Aug; 276(31):28954-60. PubMed ID: 11387320
[TBL] [Abstract][Full Text] [Related]
33. Vav1 and Ly-GDI two regulators of Rho GTPases, function cooperatively as signal transducers in T cell antigen receptor-induced pathways.
Groysman M; Hornstein I; Alcover A; Katzav S
J Biol Chem; 2002 Dec; 277(51):50121-30. PubMed ID: 12386169
[TBL] [Abstract][Full Text] [Related]
34. p38 MAPK-mediated activation of NF-kappaB by the RhoGEF domain of Bcr.
Korus M; Mahon GM; Cheng L; Whitehead IP
Oncogene; 2002 Jul; 21(30):4601-12. PubMed ID: 12096337
[TBL] [Abstract][Full Text] [Related]
35. Interactions of p62(dok) with p210(bcr-abl) and Bcr-Abl-associated proteins.
Bhat A; Johnson KJ; Oda T; Corbin AS; Druker BJ
J Biol Chem; 1998 Nov; 273(48):32360-8. PubMed ID: 9822717
[TBL] [Abstract][Full Text] [Related]
36. Rac1 function is required for Src-induced transformation. Evidence of a role for Tiam1 and Vav2 in Rac activation by Src.
Servitja JM; Marinissen MJ; Sodhi A; Bustelo XR; Gutkind JS
J Biol Chem; 2003 Sep; 278(36):34339-46. PubMed ID: 12810717
[TBL] [Abstract][Full Text] [Related]
37. Vav, a GDP/GTP nucleotide exchange factor, interacts with GDIs, proteins that inhibit GDP/GTP dissociation.
Groysman M; Russek CS; Katzav S
FEBS Lett; 2000 Feb; 467(1):75-80. PubMed ID: 10664460
[TBL] [Abstract][Full Text] [Related]
38. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.
Ren SY; Xue F; Feng J; Skorski T
Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545
[TBL] [Abstract][Full Text] [Related]
39. Vav family proteins couple to diverse cell surface receptors.
Moores SL; Selfors LM; Fredericks J; Breit T; Fujikawa K; Alt FW; Brugge JS; Swat W
Mol Cell Biol; 2000 Sep; 20(17):6364-73. PubMed ID: 10938113
[TBL] [Abstract][Full Text] [Related]
40. SH3 domain-dependent interaction of the proto-oncogene product Vav with the focal contact protein zyxin.
Hobert O; Schilling JW; Beckerle MC; Ullrich A; Jallal B
Oncogene; 1996 Apr; 12(7):1577-81. PubMed ID: 8622875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
